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Background: The European Innovation Partnership on Active and Healthy Ageing seeks an increase of two healthy
life years (HLY) at birth in the EU27 for the next 10 years. We assess the feasibility of doing so between 2010 and
2020 and the differential impact among countries by applying different scenarios to current trends in HLY.
Methods: Data comprised HLY and life expectancy (LE) at birth 2004–09 from Eurostat. We estimated HLY in
2010 in each country by multiplying the Eurostat projections of LE in 2010 by the ratio HLY/LE obtained either
from country and sex-specific linear regression models of HLY/LE on year (seven countries retaining same HLY
question) or extrapolating the average of HLY/LE in 2008 and 2009 to 2010 (20 countries and EU27). The first
scenario continued these trends with three other scenarios exploring different HLY gap reductions between 2010
and 2020. Results: The estimated gap in HLY in 2010 was 17.5 years (men) and 18.9 years (women). Assuming
current trends continue, EU27 HLY increased by 1.4 years (men) and 0.9 years (women), below the European
Innovation Partnership on Active and Healthy Ageing target, with the HLY gap between countries increasing to
18.3 years (men) and 19.5 years (women). To eliminate the HLY gap in 20 years, the EU27 must gain 4.4 HLY (men)
and 4.8 HLY (women) in the next decade, which, for some countries, is substantially more than what the current
trends suggest. Conclusion: Global targets for HLY move attention from inter-country differences and, alongside
the current economic crisis, may contribute to increase health inequalities.
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Introduction
The European Union (EU) is committed to improving the health ofits ageing population, with growing initiatives to promote active
and healthy ageing (Supplementary figure S1). Its preferred measure
is Healthy Life Years (HLY), the average remaining years spent free of
activity limitation. Health expectancies, of which HLY is one, were
developed to assess whether increases in life expectancy (LE) are due
to improvements in medical technology, which keep the old and frail
alive (resulting in an expansion of morbidity),1 or because the onset
and progression of disabling diseases are being postponed (compres-
sion of morbidity).2 As well as assessing the relationship between LE
and HLY historically, the compression of morbidity concept can be
used prospectively to set HLY targets, e.g. the European Innovation
Partnership on Active and Healthy Ageing (EIPon-AHA) target,
which seeks to increase HLY at birth by 2 years during the next 10
years, averaging 2.4 months per year. If achieved, disability would be
compressed at the EU level, as projected LE increases, at 1.9 years
(men) and 1.5 years (women) (Supplementary table S1),3 are less
than the EIPon-AHA target of 2 years.
Although the EIPon-AHA target is generally supported, especially
among those fearing that broader welfare may be sacrificed for
economic growth, there are concerns that an EU-wide target
ignores disparities between member states. These are large—in
2005, the gaps in HLY at age 50 years were a remarkable 14.5
years for men and 13.7 years for women, exceeding gaps in LE
at age 50 years (men: 9.1 years; women: 6.1 years).4 Eurostat pro-
jections assume a ‘convergence hypothesis’5 that envisages the LE
gap across the EU27 reducing between 2010 and 2020, by 1.6 years
for men and 1 year for women (Supplementary table S1), though
this is a stronger assumption than the 0.9 years (men) and 0.2 years
(women) projected during the same period by the United Nations.6
Nevertheless, though the EU, as a whole, is currently projected to
reach the target, male LE is projected to exceed 2 years for nine
countries and female LE for four countries (Supplementary table S1).
We assess whether the EIPon-AHA target is attainable for the
EU27 as a whole and what effect this will have on individual
countries and the health gaps between them. First, we examine
how LE and HLY has changed during the past 5 years in the
EU27 countries. Then we project the changes in HLY forward
from 2010–20 under various scenarios to investigate (i) the scope
to achieve the target for the EU27 as a whole and in its constituent
countries and (ii) the impact on disparities in HLY between
countries.
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Methods
To document previous trends in LE and HLY, we obtained values of
HLY and LE at birth from the eurOhex website (www.eurohex.eu),
these being identical to values from Eurostat. HLY are calculated by
Sullivan’s method7 in which the age- and sex-specific prevalence of
the health state is applied to a standard life table. For HLY, the
underlying health state question is the Global Activity Limitation
Indicator (GALI), included in the EU Statistics of Income and
Living Conditions survey (see Supplementary material for the
exact form of the GALI). Although some countries began data
collection in 2004, HLY were only available for all 25 pre-2007 EU
countries (EU25) since 2005.4 Hence, for comparability, we focussed
on the data from 2005.
Overall HLY trends are complicated because some countries made
substantial changes to the GALI question used to calculate HLY,
particularly between 2007 and 2008. Consequently, to explore pre-
liminary trends further, we concentrated on the six countries
(Belgium, France, Greece, Ireland, Slovenia and UK) where the
GALI question was essentially unchanged between 2005 and 2009,
but also included Romania, which had retained the same question
since EU accession in 2007. Values were also included for countries
involved in the pilot phase in 2004 (Belgium, France, Greece and
Ireland) to provide longer time series. To assess trends, we estimated
annual change in HLY, LE and the proportion of remaining life
spent healthy (HLY/LE) and 95% confidence intervals from the
country and sex-specific linear regression models. Further details
of methods, including sample size and non-response rates for the
EU Statistics of Income and Living Conditions 2009, are given in
Supplementary material.
We then estimated HLY in 2010 in each country by multiplying
Eurostat projections of LE in 2010 by the ratio HLY/LE obtained
either from country- and sex-specific linear regression models of
HLY/LE on year (seven countries retaining same HLY question)
or extrapolating the average of HLY/LE in 2008 and 2009 to 2010
(20 countries and EU27). Full details of methods are in the online
Supplementary material. Projecting HLY/LE rather than HLY
ensured that HLY could not exceed LE. To assess the validity of
these assumptions, we compared projected 2010 HLY with prelim-
inary true values for 20 countries and found close agreement. The
mean difference (men and women) between the predicted and
actual 2010 HLY was 0.2 years, and 84% of the values were
within 1.5 years, although the limits of agreement8 (3.4 to 3.7
years) were somewhat wider. HLY values for EU27 were the
average of HLY values for the individual countries weighted
according to population size.
Reducing inequalities is a key concern for the EU9; therefore, the
other three scenarios explored relevant implications, first alone
(Scenario 2), then in combination with the EIPon-AHA target for
each country (Scenario 3) and finally in combination with the re-
quirement that each country’s gain in HLY was at least at the level of
LE gains during the period, thus avoiding expansion of disability
(Scenario 4). In all three inequality scenarios, we considered two
reductions: a 50% gap reduction between countries with the
highest and lowest values for 10 years, equating to eliminating the
HLY gap in 20 years (A), and a 30% reduction for the 10 years, thus
eliminating the HLY gap in around 33 years (B).
Results
Past trends in LE and HLY 2005–09
In 2005, male LE in the EU25 was 75.9 years, and female LE was 81.9
years (Supplementary figure S2). Between 2005–09, LE for the EU25
increased steadily, by just over 1 year or 3.0 months per year for
men, and by 1.0 years or 2.4 months per year for women. Although
all countries showed increases in LE at birth, the gains varied. LE
increased least in Denmark (0.6 years for women) and Ireland (0.1
years for men) and most in Cyprus (2.7 years for women) and Latvia
(2.8 years for men). Differential gains in LE narrowed the gap in LE
from 13.2 years in 2005 to 11.9 years in 2009 for men but a small
increase for women from 7.3 years in 2005 to 7.6 years in 2009.
In 2005, male HLY at birth for the pre-2007 EU25 was 61.0 years,
80% of remaining life. Female HLY was greater, at 62.3 years, though
women could expect to live less of their remaining life healthy
(76%). Similar levels of HLY for men and women contrast with
women’s higher overall LE and therefore co-occur with a greater
number of years with disability [unhealthy life years (UHLY)]
(Supplementary figure S2). In contrast to the increase in LE for
men and women between 2005 and 2009, HLY showed little
change: for men an increase of 0.3 years or 0.8 months per
year and for women a decrease of 0.4 years or 1.0 months per
year. As the EIPon-AHA target equates to 2.4 months increase per
year, it was not reached for the EU25 overall during the period
2005–09.
Turning to the restricted set of countries with consistent wording
of the GALI question, even here, real increases in LE at birth from
2004–09 were not universal (Supplementary table S2). During this
period, Romania (both sexes) and Ireland (men) had no significant
increase in LE, and Romanian men had a significant decrease in
HLY. Significant increases in HLY were observed in Belgium (both
sexes), and for men in Ireland, Slovenia and the UK, all were
equating to increases of at least 2 HLY for 10 years. In Slovenia,
the HLY increase was also accompanied by a significant increase in
the proportion of remaining life spent healthy.
Projections of HLY 2010–20
Projections of HLY at birth are presented in table 1 (men) and
table 2 (women). In 2010, the gap between countries in male HLY
was estimated to be 17.5 years (from Slovakia 52.6 years to Sweden
70.1 years) and in female HLY 18.9 years (from Slovakia 52.7 years
to Malta 71.5 years). HLY projections between 2010 and 2020 were
explored under four main scenarios (tables 1 and 2). Scenario 1
assumed that recent annual changes in HLY (previously
calculated) would continue for the whole period. EU27 HLY at
birth then increases by 1.4 years (men) and 0.5 years (women),
failing to reach the 2-year EIPon-AHA target, although it would
be reached in nine countries for male HLY but only one country
(Belgium) for female HLY. Crucially, the HLY gap between
countries would increase further to 18.3 years (men) and 19.5
years (women) by 2020.
Under Scenario 2A, eliminating the HLY gap in 20 years would
result in gains for the next decade of 4.4 HLY for EU27 men (table 1)
and 4.8 HLY for EU27 women (table 2), more than double the
EIPon-AHA target. For Slovakia, which currently has the lowest
HLY at birth for men and women, this means an increase of 9
HLY (male HLY: 8.8, female HLY: 9.4) during the decade, substan-
tially more than the increase of under 2 HLY (male HLY: 1.8, female
HLY: 1.3) expected if recent annual changes continue (Scenario 1). If
the goal of eliminating the HLY gap in a 20-year period was relaxed,
then the EIPon-AHA target could be achieved by a 21–23%
reduction in the gap over the next 10 years, in women and men,
respectively, with more realistic increases for Slovakia (male HLY:
4.0, female HLY: 3.3; data not shown), although now the gap would
only be closed in 45 years. Moreover, with this reduction, the
EIPon-AHA target would be achieved by under half of the
countries (male: 13 countries, female: 5 countries). Scenario 3
therefore added the constraint that each country also had to
achieve the EIPon-AHA target of an increase in 2 HLY during the
decade resulting in Slovakia needing to achieve even greater
increases of 11 HLY (male HLY: 10.8, female HLY: 11.4) or
more than one HLY per year.
For scenario 4, in addition to closing the gap for the same periods
as Scenarios 2 and 3, projected increases in LE were included by
requiring that the number of remaining years spent unhealthy
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(LE-HLY) did not increase. Overall, this slightly attenuated the
increases in HLY required.
Discussion
We have previously reported large inequalities in health across the
EU in 2005 when the HLY indicator was first introduced.4 We have
examined trends between 2005 and 2009 both within countries and
overall, and we are the first to show that, far from diminishing,
inequalities have persisted. Indeed, although LE at birth for the
EU increased by 1 year for men and women between 2005 and
2009, HLY increased by less than half a year for men and decreased
by almost half a year for women. By applying projections of current
trends in different scenarios, we explored the extent to which
individual countries and the EU27 as a whole might reach the
EIPon-AHA target of increasing HLY at birth by 2 years by 2020.
We found that if recent trends continue, the EIPon-AHA target
could be met by several countries, predominantly Eastern
European ones including Estonia, Latvia, Lithuania and Hungary,
despite LE in these countries being projected to increase more than
in Western European countries. On the other hand, France (women)
and Romania (both sexes) are unlikely to meet the target, as,
extrapolating recent trends, they will lose rather than gain HLY in
the next decade. Overall, the EIPon-AHA target would not be
reached by the EU27 as a whole, and more critically, HLY
inequalities would increase further.
As LE at birth is expected to increase by 2–2.5 years every decade
in low mortality countries,10,11 increasing HLY at birth by 2 years is
a minimum to avoid expansion of UHLY at the European level.
Nevertheless, this strategy will not automatically reduce the
existing HLY gaps between countries; therefore, this ‘average’
target should be accompanied by a second one, focussed on
reducing the HLY disparities. Our other scenarios looked at the
impact of reducing the gaps alone, alongside an increase of 2 HLY
for each country and finally together with no increase in UHLY. The
large gains in HLY, of between 0.5 and one HLY per year during the
decade, required by the Baltic and Eastern European countries for
ultimate elimination of HLY gaps in 20 or 30 years would only be
reached by one country, i.e. Slovenia.
To obtain HLY in 2010, we assumed that the proportion of
remaining life spent healthy in most countries would remain at
the average of 2008 and 2009 values. This is an obvious limitation
but a standard approach,12 not unrealistic when compared with
preliminary 2010 HLY values for 20 countries. When time series
are available for these countries, we can replace this assumption
by the empirical trends, as we have already done for the seven
countries with available data. A further limitation is that, for these
seven countries, the time series were too short to adequately estimate
anything other than a linear trend, but again longer time series will
enable the linear trend assumption to be tested. We concentrated on
the effect of reducing the overall gap, which will depend strongly on
outliers. Nevertheless, our findings appear relatively robust, as, at
least with the scenario of continued current trends, the interquartile
range for predicted HLY in 2010 for men is 16.2 years, 1.3 years less
than the overall gap, and would still increase, to 16.8 years, by 2020.
An inevitable limitation of analyses such as these is that they must
predict the future on the basis of past knowledge; although the
future will be different, it is difficult to know in what way.
Table 1 HLY at birth in 2010, current annual increase in HLY and projected increase in HLY between 2010 and 2020 under various scenarios
for EU27 countries, males
Country Projected increase in HLY at birth between 2010 and 2020
HLY 2010 Scenario1: current
trends prevail
Scenario 2: reduction
of HLY gaps by
Scenario 3: HLY increase 2 years
for country and reduction
in HLY gaps by
Scenario 4: no increase in
UHLY for country and
reduction in the HLY gaps by
A:50% B:30% A:50% B:30% A:50% B:30%
Slovakiaa 52.6 1.8 8.8 5.3 10.8 7.3 10.2 6.7
Latviaa 52.9 2.2 8.6 5.2 10.6 7.2 10.0 6.6
Estoniaa 54.5 2.1 7.8 4.7 9.8 6.7 9.2 6.1
Hungarya 55.5 2.1 7.3 4.4 9.3 6.4 8.7 5.8
Germanya 56.7 1.2 6.7 4.0 8.7 6.0 8.1 5.4
Lithuaniaa 56.7 2.5 6.7 4.0 8.7 6.0 8.1 5.4
Finlanda 58.4 1.4 5.9 3.5 7.9 5.5 7.3 4.9
Polanda 58.7 2.1 5.7 3.4 7.7 5.4 7.1 4.8
Portugala 58.8 1.4 5.7 3.4 7.7 5.4 7.1 4.8
Austriaa 58.9 1.2 5.6 3.4 7.6 5.4 7.0 4.8
Romaniab 59.5 2.2 5.3 3.2 7.3 5.2 6.7 4.6
Sloveniab 61.1 8.1 4.5 2.7 6.5 4.7 5.9 4.1
CzechRepublica 61.3 1.7 4.4 2.6 6.4 4.6 5.8 4.0
Denmarka 61.9 1.3 4.1 2.5 6.1 4.5 5.5 3.9
Netherlandsa 62.2 1.1 4.0 2.4 6.0 4.4 5.4 3.8
Bulgariaa 62.4 2.3 3.8 2.3 5.8 4.3 5.2 3.7
Franceb 62.6 1.2 3.8 2.3 5.8 4.3 5.2 3.7
Italya 62.9 1.2 3.6 2.2 5.6 4.2 5.0 3.6
Irelandb 63.4 1.9 3.4 2.0 5.4 4.0 4.8 3.4
Spaina 63.6 1.3 3.3 2.0 5.3 4.0 4.7 3.4
Cyprusa 64.6 1.3 2.7 1.6 4.7 3.6 4.1 3.0
Belgiumb 64.7 8.0 2.7 1.6 4.7 3.6 4.1 3.0
Luxembourga 64.9 1.3 2.6 1.6 4.6 3.6 4.0 3.0
UKb 65.0 1.0 2.6 1.5 4.6 3.5 4.0 2.9
Greeceb 66.1 2.2 2.0 1.2 4.0 3.2 3.4 2.6
Maltaa 69.4 1.5 0.3 0.2 2.3 2.2 1.7 1.6
Swedena 70.1 1.2 0.0 0.0 2.0 2.0 1.4 1.4
EU27a 61.3 1.4 4.4 2.6 6.4 4.6 5.8 4.0
a: HLY2010 values based on 2008–09 values.
b: HLY2010 values based on 2004/2005–09 values.
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Consequently, this article looks at the implications of achieving
certain objectives while recognizing that there are many factors
that cannot be taken into account to determine whether they can
be achieved. An example is the economic crisis that has gripped
Europe since 2008. Though short-term effects on mortality have
been shown (increased suicides but reduced traffic deaths),13,14 it
is much more difficult to identify long-term effects on morbidity or
mortality. One possibility that must be considered is whether the
substantial gains in survival at older ages seen in recent decades, and
thought to be driven largely by improvements in the management of
chronic disorders, such as hypertension and its complications, par-
ticularly in older patients,15 will continue given policies of austerity
reducing access to health care in some countries.16 However, this is
beyond the scope of this article. Finally, particular caution must be
exercised in relation to projections for two of the Baltic states, Latvia
and Lithuania, which experienced transient declines in LE during the
period 2004–07, followed by rapid increases, causing difficulties
when calculating our baseline scenario.17
Increasing HLY by 2 years and reducing gaps will require action
on many fronts as well as measures designed to address both the
level and distribution of HLYs. There is growing recognition of the
imperative to address socio-economic inequalities in health at both
national and international levels,18,19 which include housing quality,
access to health care, unemployment, work conditions as well as
education, perhaps the most often cited determinant of health20
and one we have shown to account for some of the variation in
HLY across the EU25.4 Socio-economic inequalities in health
across the EU25 have been estimated to account for 20% of the
total cost of health care and 15% of the total costs of social
security benefits.21
Policies must also address factors that predominantly cut lives
short prematurely, such as deaths from injuries and violence or
smoking and those that leave people alive but disabled, such as
poor diet, obesity and inadequate physical activity. A particular
priority will be to reduce exposure to risk factors in middle age,
and especially smoking, coupled with policies that help people to
remain confident and engaged with life, factors shown to correlate
with successful ageing.22 These considerations highlight the
importance of comprehensive health improvement strategies,
reaching from the underlying determinants of health to responses
to established disease. Nevertheless, these strategies may not always
have the desired effect on increasing HLY. Conditions such as
cognitive impairment and cardiovascular disease impact on both
disability and mortality, others (arthritis and visual impairment)
affect disability only, whereas cancer predominantly affects
mortality.23,24 Countries need to consider the balance between
investment in life-saving medical interventions, rehabilitation for
disabling conditions or prevention (of both disabling and fatal
conditions), as the former could result in increased LE but with a
likelihood of increased disability prevalence.
An important barrier to reducing the health gaps across the EU is
the lack of evidence of what works in narrowing inequalities. A
recent systematic review found little evidence, apart from some,
albeit not strong, in the areas of housing and work conditions.20
The EU provides a ready ‘population laboratory’ for international
comparative research, which should be fully exploited alongside
the more systematic diffusion of successful national interventions
to other countries as recently highlighted by Futurage.25
The prime concern for both the Lisbon Strategy26 and its
successor Europe 202027 is to create sustainable economic
Table 2 HLY at birth in 2010, current annual increase in HLY and projected increase in HLY between 2010 and 2020 under various scenarios
for EU27 countries, females
Country Projected increase in HLY at birth between 2010 and 2020
HLY 2010 Scenario1:
current trends
prevail
Scenario 2: reduction
of HLY gaps by
Scenario 3: HLY increase 2 years
for country and reduction in
HLY gaps by
Scenario 4: no increase in
UHLY for country and
reduction in the HLY gaps by
A:50% B:30% A:50% B:30% A:50% B:30%
Slovakiaa 52.7 1.3 9.4 5.7 11.4 7.7 10.9 7.2
Latviaa 55.4 1.5 8.1 4.8 10.1 6.8 9.6 6.3
Portugala 56.9 1.0 7.3 4.4 9.3 6.4 8.8 5.9
Germanya 57.8 1.0 6.9 4.1 8.9 6.1 8.4 5.6
Hungarya 58.3 1.6 6.6 4.0 8.6 6.0 8.1 5.5
Estoniaa 58.5 1.3 6.5 3.9 8.5 5.9 8.0 5.4
Finlanda 58.8 1.0 6.4 3.8 8.4 5.8 7.9 5.3
Austriaa 60.0 1.0 5.8 3.5 7.8 5.5 7.3 5.0
Netherlandsa 60.1 1.0 5.7 3.4 7.7 5.4 7.2 4.9
Denmarka 60.7 1.3 5.4 3.3 7.4 5.3 6.9 4.8
Lithuaniaa 61.0 1.5 5.3 3.2 7.3 5.2 6.8 4.7
Sloveniab 61.0 0.3 5.3 3.2 7.3 5.2 6.8 4.7
Romaniab 61.1 5.2 5.2 3.1 7.2 5.1 6.7 4.6
Italya 61.9 0.9 4.8 2.9 6.8 4.9 6.3 4.4
Franceb 62.6 2.7 4.5 2.7 6.5 4.7 6.0 4.2
Polanda 62.8 1.4 4.4 2.6 6.4 4.6 5.9 4.1
CzechRepublica 63.0 1.3 4.3 2.6 6.3 4.6 5.8 4.1
Spaina 63.0 0.8 4.3 2.6 6.3 4.6 5.8 4.1
Belgiumb 64.3 9.1 3.6 2.2 5.6 4.2 5.1 3.7
Irelandb 64.8 1.7 3.4 2.0 5.4 4.0 4.9 3.5
Luxembourga 65.0 1.2 3.3 2.0 5.3 4.0 4.8 3.5
Cyprusa 65.5 1.1 3.0 1.8 5.0 3.8 4.5 3.3
UnitedKingdomb 66.0 1.6 2.8 1.7 4.8 3.7 4.3 3.2
Bulgariaa 66.0 1.8 2.8 1.7 4.8 3.7 4.3 3.2
Greeceb 66.7 0.5 2.4 1.5 4.4 3.5 3.9 3.0
Swedena 69.3 1.2 1.1 0.7 3.1 2.7 2.6 2.2
Maltaa 71.5 1.3 0.0 0.0 2.0 2.0 1.5 1.5
EU27a 61.9 0.5 4.8 2.9 6.8 4.9 6.3 4.4
a: HLY2010 values based on 2008–09 values.
b: HLY2010 values based on 2004/2005–09 values.
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growth in Europe. This ‘global’ target, like the EIPon-AHA target,
moves attention from inter-country differences and, alongside the
current economic crisis with its winners and losers, is likely to
increase health inequalities.28 The EU, in accordance with the
goal of Health 2020 of reducing health inequalities,29 should
urgently invest in research to monitor, understand and close
the unacceptable level of health inequalities across European
countries.
Supplementary Data
Supplementary data are available at EURPUB online.
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Key points
 The EU is committed to active and healthy ageing, but its
target for HLY applies to the EU as a whole and assumes
convergence across countries.
 On the basis of recent trends, the EU target will not be
achieved, and inter-country disparities will widen further.
 Achievement of the EU target will require action on many
fronts but especially to reduce health inequalities.
 To be effective, policies must be based on evidence of what
works, although that evidence is currently limited.
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